Skip to main content
Caplight Logo









Atlanthera

Atlanthera

Private
Saint-HerblainHealthcare & Life Scienceshttps://www.atlanthera.com/

Last Round

VC Round

Jan 19, 2017

Total Funding Raised

$1.1M

Company Overview

Atlanthera is a biotechnology company that develops innovative drug delivery solutions for the treatment of bone diseases and bone cancer.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

targeted drug deliveryhydroxybisphosphonateHBPbone disease therapeuticsvectorization technologydrug conjugationbiotech R&Dsmall molecule drugsoncology therapeuticsdrug discoverybiopharma licensingbone metastasis treatmentdrug delivery platformsmart drugsprecision medicine

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Atlanthera Comparables

Compare Atlanthera with similar companies based on industry and business-model similarity.

Atlanthera comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
BioVinc
88%
Taithera, Inc.
85%
Mesentech Inc.
83%

Atlanthera Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundJan 19, 2017
SeedApr 1, 2014

Key People

Founding team and executive leadership

Ronan Le Bot

CEO

Executive Team

Atlanthera Investors

Notable investors and investment history

Atlanthera investors
InvestorRounds
Fair WestSeed, VC Round
GO CapitalSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 1, 2014

    $1.1M round led by GO Capital and Fair West.

Atlanthera Filings

Explore SEC and related filing metadata, where available.

Atlanthera filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Atlanthera's valuation, stock price, and market status.

Is Atlanthera a public or private company?

Atlanthera is a private company.

What is the current stock price of Atlanthera?

Atlanthera is a private company with no public stock price. No recent secondary market data is available.

How much is Atlanthera worth (valuation)?

Valuation information for Atlanthera is not publicly available.

Can I buy Atlanthera stock?

Atlanthera shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Atlanthera's last funding round?

Atlanthera's most recent funding round was VC Round on January 19, 2017.

Who are the main investors in Atlanthera?

Key investors in Atlanthera include Fair West, GO Capital.

Will Atlanthera IPO soon?

No public IPO plans have been announced for Atlanthera.

How can I track Atlanthera secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Atlanthera's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSaint-Herblain
Employee Range8
Year Founded2010
Last FundingJan 19, 2017

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?